N-Linked Glycosylation in the Hemagglutinin of Influenza A Viruses

키워드

참고문헌 (59)

1. Taubenberger JK, "Influenza virus evolution, host adaptation, and pandemic formation", Cell Host Microbe, 7, pp.440~451 (2010)
2. Salomon R, "The influenza virus enigma", Cell, 136, pp.402~410 (2009)
3. Tong S, "A distinct lineage of influenza A virus from bats", Proc Natl Acad Sci U S A, 109, pp.4269~4274 (2012)
4. Bouvier NM, "The biology of influenza viruses", Vaccine, 26(Suppl 4), pp.49~53 (2008)
6. Barr IG, "Epidemiological, antigenic and genetic characteristics of seasonal influenza A(H1N1), A(H3N2) and B influenza viruses: basis for the WHO recommendation on the composition of influenza vaccines for use in the 2009-2010 Northern Hemisphere season", Vaccine, 28, pp.1156~1167 (2010)
7. de Jong JC, "Mismatch between the 1997", 1998 influenza vaccine and the major epidemic A(H3N2) virus strain as the cause of an inadequate vaccine-induced antibody response to this strain in the elderly, 2000, pp.61, 94~99
8. Carrat F, "Influenza vaccine: the challenge of antigenic drift", Vaccine, 25, pp.6852~6862 (2007)
9. Plotkin JB, "Hemagglutinin sequence clusters and the antigenic evolution of influenza A virus", Proc Natl Acad Sci U S A, 99, pp.6263~6268 (2002)
10. Palese P, "Making better influenza virus vaccines?", Emerg Infect Dis, 12, pp.61~65 (2006)
11. Kreijtz JH, "Immune responses to influenza virus infection", Virus Res, 162, pp.19~30 (2011)
12. Corti D, "A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins", Science, 33, pp.850~856 (2011)
13. Fleishman SJ, "Computational design of proteins targeting the conserved stem region of influenza hemagglutinin", Science, 332, pp.816~821 (2011)
14. Krause JC, "A broadly neutralizing human monoclonal antibody that recognizes a conserved, novel epitope on the globular head of the influenza H1N1 virus hemagglutinin", J Virol, 85, pp.10905~10908 (2011)
15. Whittle JR, "Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin", Proc Natl Acad Sci U S A, 108, pp.14216~14221 (2011)
16. Kilbourne ED, "Purified influenza A virus N2 neuraminidase vaccine is immunogenic and non-toxic in humans", Vaccine, 13, pp.1799~1803 (1995)
17. Neirynck S, "A universal influenza A vaccine based on the extracellular domain of the M2 protein", Nat Med, 5, pp.1157~1163 (1999)
18. Nayak B, "Contributions of the avian influenza virus HA, NA, and M2 surface proteins to the induction of neutralizing antibodies and protective immunity", J Virol, 84, pp.2408~2420 (2010)
19. Wei CJ, "Cross-neutralization of 1918 and 2009 influenza viruses: role of glycans in viral evolution and vaccine design", Sci Transl Med, 2, pp.24ra21~ (2010)
20. Sun S, "Glycosylation site alteration in the evolution of influenza A (H1N1) viruses", PLoS One, 6, pp.22844~ (2011)
21. Schulze IT, "Effects of glycosylation on the properties and functions of influenza virus hemagglutinin", J Infect Dis, 176(Suppl 1), pp.24~28 (1997)
22. Aytay S, "Single amino acid substitutions in the hemagglutinin can alter the host range and receptor binding properties of H1 strains of influenza A virus", J Virol, 65, pp.3022~3028 (1991)
23. Gambaryan AS, "Effects of host-dependent glycosylation of hemagglutinin on receptor-binding properties on H1N1 human influenza A virus grown in MDCK cells and in embryonated eggs", Virology, 247, pp.170~177 (1998)
24. Deshpande KL, "Glycosylation affects cleavage of an H5N2 influenza virus hemagglutinin and regulates virulence", Proc Natl Acad Sci U S A, 84, pp.36~40 (1987)
25. Vigerust DJ, "Virus glycosylation: role in virulence and immune interactions", Trends Microbiol, 15, pp.211~218 (2007)
26. Skehel JJ, "A carbohydrate side chain on hemagglutinins of Hong Kong influenza viruses inhibits recognition by a monoclonal antibody", Proc Natl Acad Sci U S A, 81, pp.1779~1783 (1984)
27. Xu R, "Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus", Science, 328, pp.357~360 (2010)
28. Fukuyama S, "The pathogenesis of influenza virus infections: the contributions of virus and host factors", Curr Opin Immunol, 23, pp.481~486 (2011)
29. Luo M., "Influenza virus entry", Adv Exp Med Biol, 726, pp.201~221 (2012)
30. Gerhard W., "The role of the antibody response in influenza virus infection", Curr Top Microbiol Immunol, 260, pp.171~190 (2001)
31. Okuno Y, "A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains", J Virol, 67, pp.2552~2558 (1993)
32. Corti D, "Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine", J Clin Invest, 120, pp.1663~1673 (2010)
33. Sun S, "Prediction of biological functions on glycosylation site migrations in human influenza H1N1 viruses", PLoS One, 7, pp.32119~ (2012)
34. Das SR, "Glycosylation focuses sequence variation in the influenza A virus H1 hemagglutinin globular domain", PLoS Pathog, 6, pp.1001211~ (2010)
35. Das SR, "Fitness costs limit influenza A virus hemagglutinin glycosylation as an immune evasion strategy", Proc Natl Acad Sci U S A, 108, pp.1417~1422 (2011)
36. Schwarz F, "Mechanisms and principles of N-linked protein glycosylation", Curr Opin Struct Biol, 21, pp.576~582 (2011)
37. Alberts B, "Molecular biology of the cell. 5th ed" (2008), Garland Science
38. Ohuchi M, "Regulation of receptor binding affinity of influenza virus hemagglutinin by its carbohydrate moiety", J Virol, 71, pp.8377~8384 (1997)
39. Wagner R, "Interdependence of hemagglutinin glycosylation and neuraminidase as regulators of influenza virus growth: a study by reverse genetics", J Virol, 74, pp.6316~6323 (2000)
40. Tsuchiya E, "Effect of addition of new oligosaccharide chains to the globular head of influenza A", H2N2 virus haemagglutinin on the intracellular transport and biological activities of the molecule, 2002, pp.83(Pt 5), 1137~1146
41. Vigerust DJ, "N-linked glycosylation attenuates H3N2 influenza viruses", J Virol, 81, pp.8593~8600 (2007)
42. Caton AJ, "The antigenic structure of the influenza virus A", PR, 34 hemagglutinin (H1 subtype), pp.Cell, 1982[DOI]
43. Reading PC, "Loss of a single N-linked glycan from the hemagglutinin of influenza virus is associated with resistance to collectins and increased virulence in mice", Respir Res, 10, pp.117~ (2009)
44. Tate MD, "Glycosylation of the hemagglutinin modulates the sensitivity of H3N2 influenza viruses to innate proteins in airway secretions and virulence in mice", Virology, 413, pp.84~92 (2011)
45. Tate MD, "Specific sites of N-linked glycosylation on the hemagglutinin of H1N1 subtype influenza A virus determine sensitivity to inhibitors of the innate immune system and virulence in mice", J Immunol, 187, pp.1884~1894 (2011)
46. Rudneva IA, "Restoration of virulence of escape mutants of H5 and H9 influenza viruses by their readaptation to mice", J Gen Virol, 86(Pt 10), pp.2831~2838 (2005)
47. O’Donnell CD, "Antibody Pressure by a Human Monoclonal Antibody Targeting the 2009 Pandemic H1N1 Virus Hemagglutinin Drives the Emergence of a Virus with Increased Virulence in Mice", MBio, 3, pp.e00120~e00112 (2012)
48. Reading PC, "Glycosylation as a target for recognition of influenza viruses by the innate immune system", Adv Exp Med Biol, 598, pp.279~292 (2007)
49. Rogers GN, "Receptor binding properties of human and animal H1 influenza virus isolates", Virology, 173, pp.317~322 (1989)
50. Connor RJ, "Paulson JC. Receptor specificity in human, avian, and equine H2 and H3 influenza virus isolates", Virology, 205, pp.17~23 (1994)
51. Rogers GN, "Single amino acid substitutions in influenza haemagglutinin change receptor binding specificity", Nature, 304, pp.76~78 (1983)
52. Matrosovich M, "Early alterations of the receptor-binding properties of H1, H2, and H3 avian influenza virus hemagglutinins after their introduction into mammals", J Virol, 74, pp.8502~8512 (2000)
53. Nobusawa E, "Change in receptor-binding specificity of recent human influenza A viruses (H3N2): a single amino acid change in hemagglutinin altered its recognition of sialyloligosaccharides", Virology, 278, pp.587~596 (2000)
54. Crecelius DM, "Biological properties of a hemagglutinin mutant of influenza virus selected by host cells", Virology, 139, pp.164~177 (1984)
55. Deom CM, "Host cell-mediated selection of a mutant influenza A virus that has lost a complex oligosaccharide from the tip of the hemagglutinin", Proc Natl Acad Sci U S A, 83, pp.3771~3775 (1986)
56. Gamblin SJ, "The structure and receptor binding properties of the 1918 influenza hemagglutinin", Science, 303, pp.1838~1842 (2004)
57. Wang W, "Glycosylation at 158N of the hemagglutinin protein and receptor binding specificity synergistically affect the antigenicity and immunogenicity of a live attenuated H5N1 A", Vietnam, 2004 vaccine virus in ferrets, pp.J Virol, 2010[DOI]
58. Gao Y, "Identification of amino acids in HA and PB2 critical for the transmission of H5N1 avian influenza viruses in a mammalian host", PLoS Pathog, 5, pp.1000709~ (2009)
59. Wang CC, "Glycans on influenza hemagglutinin affect receptor binding and immune response", Proc Natl Acad Sci U S A, 106, pp.18137~18142 (2009)

관련 논문AI추천